PURPOSE: The financial toxicity of anticancer drugs is well-documented, but little is known
about the costs of drugs used to manage cancer-associated symptoms. METHODS: We …

Simple Summary This review discusses treatment approaches for providing pain relief to
oncological patients affected by pain caused by nerve damage due to the tumor, also known …

Objective This systematic review analyzed the effects of physical exercise programs in
patients with cancer undergoing chemotherapy on chemotherapy-induced peripheral …

Objective To provide an updated analysis of the efficacy and safety of drugs for the
management of neuropathic pain (NP) after spinal cord injury (SCI) based on Bayesian …

Chemotherapy-induced peripheral neuropathy (CIPN) can cause loss of independence and
poor quality of life (QoL) due to severe disabilities, but in spite of its importance there is still a …

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting toxicity
that affects 30%–40% of patients undergoing cancer treatment. Although multiple …

Oxaliplatin (OXA) is a third-generation platinum compound with clinical activity in multiple
solid tumors. Due to the repetition of chemotherapy cycle, OXA-induced chronic neuropathy …

Purpose The aim in this review was to explore recent advances in chemotherapy-induced
peripheral neuropathy (CIPN) management interventions and to identify the implications for …

Purpose Patients with cancer are using cannabis for self-treatment. The reasons,
experienced effects, and prevalence of use are unknown in the European general …

Purpose Chemotherapy-induced peripheral neuropathy ((CI) PN) becomes chronic in 30%
of cancer patients. Knowledge of predictors of chronic (CI) PN and related impairments in …